10x Genomics's Total Assets for the quarter that ended in Mar. 2024 was $922.9 Mil.
Warning Sign:
If a company builds assets at 55.5% a year, faster than its revenue growth rate of 15.1% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, 10x Genomics's average Total Assets Growth Rate was -7.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 29.50% per year.
During the past 5 years, the average Total Assets Growth Rate was 55.50% per year.
During the past 7 years, 10x Genomics's highest 3-Year average Total Assets Growth Rate was 112.40%. The lowest was 29.50%. And the median was 71.30%.
The historical data trend for 10x Genomics's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
10x Genomics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
10x Genomics's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
10x Genomics Total Assets Related Terms
Thank you for viewing the detailed overview of 10x Genomics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TXG has been successfully added to your 